Literature DB >> 15930027

Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new.

Stephen S Hecht1.   

Abstract

A new study demonstrates that lifetime whole-body exposure of B6C3F1 mice to high doses of cigarette smoke robustly increases lung cancer incidence compared with sham exposed animals. This is the first study to demonstrate a strong effect of inhaled cigarette smoke on lung cancer in an animal model. This commentary attempts to put the new results in perspective with the existing literature on cigarette smoke inhalation studies in animals and discusses strengths, limitations and possible applications of available models.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930027     DOI: 10.1093/carcin/bgi148

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

Review 1.  Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.

Authors:  Silvio De Flora; Gancho Ganchev; Marietta Iltcheva; Sebastiano La Maestra; Rosanna T Micale; Vernon E Steele; Roumen Balansky
Journal:  Trends Pharmacol Sci       Date:  2015-12-23       Impact factor: 14.819

2.  Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

Authors:  Chinthalapally V Rao; Jagan Mohan R Patlolla; Li Qian; Yuting Zhang; Misty Brewer; Altaf Mohammed; Dhimant Desai; Shantu Amin; Stan Lightfoot; Levy Kopelovich
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

Review 3.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

4.  Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer.

Authors:  Stephen S Hecht; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

Review 5.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

6.  Myeloid-derived suppressor cells in the development of lung cancer.

Authors:  Myrna L Ortiz; Lily Lu; Indu Ramachandran; Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2013-10-18       Impact factor: 11.151

7.  Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.

Authors:  Junya Fujimoto; Humam Kadara; Taoyan Men; Carolyn van Pelt; Dafna Lotan; Reuben Lotan
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

8.  Prenatal N-acetylcysteine prevents cigarette smoke-induced lung cancer in neonatal mice.

Authors:  Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Vernon E Steele; Silvio De Flora
Journal:  Carcinogenesis       Date:  2009-05-20       Impact factor: 4.944

9.  Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice.

Authors:  Fekadu Kassie; Ilze Matise; Mesfin Negia; David Lahti; Yunqian Pan; Robyn Scherber; Pramod Upadhyaya; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

10.  Smoking-induced immune deviation contributes to progression of bladder and other cancers.

Authors:  Jessica M Clement; Fei Duan; Pramod K Srivastava
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.